Resource utilization and cost assessment of a proactive penicillin allergy de-labeling program for low-risk inpatients.
Derek LanoueAdhora MirCarl van WalravenTimothy OlynychCaroline NottDerek R MacFaddenPublished in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2024)
A proactive approach, including a direct oral challenge for low-risk in-patients with penicillin allergy, appears safe and feasible. Similar programs could be implemented at other institutions across Canada to increase access to allergy assessment.